StanChart PE sells 5% in Aurobindo Pharma

Standard Chartered Private Equity has sold half of its 5 per cent stake in Aurobindo Pharma for about Rs 95 crore ($21 million), reports The Economic Times. That's a little less than 100 per cent return on its investment made three years back. StanChart PE had picked up 4.5 per cent for Rs 89 crore, and later added another 0.5 per cent for Rs 12 crore. Now the company has sold shares in open market through block deals. The company is left with Rs 2.5 per cent in the company which is currently valued at Rs 96 crore.